VOYA Investment Management’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-14,031
Closed -$236K – 2923
2022
Q4
$236K Sell
14,031
-118
-0.8% -$2.04K ﹤0.01% 2485
2022
Q3
$210K Buy
+14,149
New +$280K ﹤0.01% 2581
2022
Q2
– Sell
-6,998
Closed -$264K – 2856
2022
Q1
$264K Buy
6,998
+296
+4% +$13.1K ﹤0.01% 2230
2021
Q4
$416K Sell
6,702
-170
-2% -$12.9K ﹤0.01% 2123
2021
Q3
$588K Buy
6,872
+220
+3% +$13.8K ﹤0.01% 1944
2021
Q2
$412K Sell
6,652
-254
-4% -$12.9K ﹤0.01% 2204
2021
Q1
$337K Buy
+6,906
New +$333K ﹤0.01% 2261

Other funds holding OPRX

VOYA Investment Management's OPRX Position: Q1 2023 in Review

VOYA Investment Management sold out of OptimizeRx (OPRX) in Q1 2023, closing a stake of 14,031 shares — an estimated $236K sold.

VOYA Investment Management first reported a position in OPRX in Q1 2021 and held it in 7 quarters. The position peaked at $588K in Q3 2021. 110 funds tracked by Wall St. Rank hold OPRX as of Q1 2023.

  • VOYA Investment Management reported no remaining OptimizeRx position as of Q1 2023 after selling out during the quarter.
  • VOYA Investment Management sold 14,031 OptimizeRx shares in Q1 2023, an estimated $236K.
  • VOYA Investment Management first reported a position in OptimizeRx in Q1 2021 and held it in 7 quarters.
  • VOYA Investment Management's OptimizeRx position peaked at $588K in Q3 2021.
  • 110 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2023.

Based on VOYA Investment Management's 13F filing for Q1 2023, filed 15 May 2023.